These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 20518582)

  • 61. Rotavirus vaccines: an overview.
    Dennehy PH
    Clin Microbiol Rev; 2008 Jan; 21(1):198-208. PubMed ID: 18202442
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficacy of a pentavalent human-bovine reassortant rotavirus vaccine against rotavirus gastroenteritis among American Indian children.
    Grant LR; Watt JP; Weatherholtz RC; Moulton LH; Reid R; Santosham M; O'Brien KL
    Pediatr Infect Dis J; 2012 Feb; 31(2):184-8. PubMed ID: 22252206
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Postmarketing monitoring of intussusception after RotaTeq vaccination--United States, February 1, 2006-February 15, 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Mar; 56(10):218-22. PubMed ID: 17363890
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Live attenuated tetravalent (G1-G4) bovine-human reassortant rotavirus vaccine (BRV-TV): Randomized, controlled phase III study in Indian infants.
    Saluja T; Palkar S; Misra P; Gupta M; Venugopal P; Sood AK; Dhati RM; Shetty A; Dhaded SM; Agarkhedkar S; Choudhury A; Kumar R; Balasubramanian S; Babji S; Adhikary L; Dupuy M; Chadha SM; Desai F; Kukian D; Patnaik BN; Dhingra MS
    Vaccine; 2017 Jun; 35(28):3575-3581. PubMed ID: 28536027
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of human rotavirus vaccine on severe diarrhea in African infants.
    Madhi SA; Cunliffe NA; Steele D; Witte D; Kirsten M; Louw C; Ngwira B; Victor JC; Gillard PH; Cheuvart BB; Han HH; Neuzil KM
    N Engl J Med; 2010 Jan; 362(4):289-98. PubMed ID: 20107214
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants.
    Kulkarni PS; Desai S; Tewari T; Kawade A; Goyal N; Garg BS; Kumar D; Kanungo S; Kamat V; Kang G; Bavdekar A; Babji S; Juvekar S; Manna B; Dutta S; Angurana R; Dewan D; Dharmadhikari A; Zade JK; Dhere RM; Fix A; Power M; Uprety V; Parulekar V; Cho I; Chandola TR; Kedia VK; Raut A; Flores J;
    Vaccine; 2017 Oct; 35(45):6228-6237. PubMed ID: 28967523
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian children in the second year of life.
    Bhandari N; Rongsen-Chandola T; Bavdekar A; John J; Antony K; Taneja S; Goyal N; Kawade A; Kang G; Rathore SS; Juvekar S; Muliyil J; Arya A; Shaikh H; Abraham V; Vrati S; Proschan M; Kohberger R; Thiry G; Glass R; Greenberg HB; Curlin G; Mohan K; Harshavardhan GV; Prasad S; Rao TS; Boslego J; Bhan MK;
    Vaccine; 2014 Aug; 32 Suppl 1():A110-6. PubMed ID: 25091663
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Results from a randomized clinical trial of coadministration of RotaTeq, a pentavalent rotavirus vaccine, and NeisVac-C, a meningococcal serogroup C conjugate vaccine.
    Vesikari T; Karvonen A; Borrow R; Kitchin N; Baudin M; Thomas S; Fiquet A
    Clin Vaccine Immunol; 2011 May; 18(5):878-84. PubMed ID: 21389149
    [TBL] [Abstract][Full Text] [Related]  

  • 69. RotaTeq: Progress toward developing world access.
    Goveia MG; Nelson CB; Ciarlet M
    J Infect Dis; 2010 Sep; 202 Suppl():S87-92. PubMed ID: 20684723
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Rotavirus infection and the current status of rotavirus vaccines.
    Chen SC; Tan LB; Huang LM; Chen KT
    J Formos Med Assoc; 2012 Apr; 111(4):183-93. PubMed ID: 22526206
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pharmacoeconomic spotlight on rotavirus vaccine RIX4414 (Rotarix™) in developed countries.
    Plosker GL
    Drugs R D; 2012 Dec; 12(4):239-44. PubMed ID: 23017130
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Development of a pentavalent rotavirus vaccine against prevalent serotypes of rotavirus gastroenteritis.
    Heaton PM; Goveia MG; Miller JM; Offit P; Clark HF
    J Infect Dis; 2005 Sep; 192 Suppl 1():S17-21. PubMed ID: 16088800
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Oral live attenuated human rotavirus vaccine (Rotarix™) offers sustained high protection against severe G9P[8] rotavirus gastroenteritis during the first two years of life in Brazilian children.
    Justino MC; Araújo EC; van Doorn LJ; Oliveira CS; Gabbay YB; Mascarenhas JD; Miranda YS; Guerra Sde F; Silva VB; Linhares AC
    Mem Inst Oswaldo Cruz; 2012 Nov; 107(7):846-53. PubMed ID: 23147138
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A Phase III open-label, randomized, active controlled clinical study to assess safety, immunogenicity and lot-to-lot consistency of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants.
    Rathi N; Desai S; Kawade A; Venkatramanan P; Kundu R; Lalwani SK; Dubey AP; Venkateswara Rao J; Narayanappa D; Ghildiyal R; Gogtay N; Venugopal P; Palkar S; Munshi R; Kang G; Babji S; Bavdekar A; Juvekar S; Ganguly N; Niyogi P; Ghosh Uttam K; Rajani HS; Kondekar A; Kumbhar D; Mohanlal S; Agarwal MC; Shetty P; Antony K; Gunale B; Dharmadhikari A; Tang Y; Kulkarni PS; Flores J
    Vaccine; 2018 Dec; 36(52):7943-7949. PubMed ID: 30420116
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Concomitant use of an oral live pentavalent human-bovine reassortant rotavirus vaccine with licensed parenteral pediatric vaccines in the United States.
    Rodriguez ZM; Goveia MG; Stek JE; Dallas MJ; Boslego JW; DiNubile MJ; Heaton PM
    Pediatr Infect Dis J; 2007 Mar; 26(3):221-7. PubMed ID: 17484218
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pentavalent human-bovine reassortant rotavirus vaccine: a review of its efficacy and safety in preventing acute rotavirus gastroenteritis in healthy infants.
    Caple J
    Drugs Today (Barc); 2006 May; 42(5):313-9. PubMed ID: 16801994
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Immunogenicity of the pentavalent rotavirus vaccine in African infants.
    Armah GE; Breiman RF; Tapia MD; Dallas MJ; Neuzil KM; Binka FN; Sow SO; Ojwando J; Ciarlet M; Steele AD
    Vaccine; 2012 Apr; 30 Suppl 1():A86-93. PubMed ID: 22520142
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cost-effectiveness analysis of the implementation of a National Immunization Program for rotavirus vaccination in a country with a low rotavirus gastroenteritis-related mortality: A South Korean study.
    Lee H; Park SY; Clark A; Debellut F; Pecenka C; Kim DS; Kim HM; Kim JH; Cho H; Kim AY; Lee M; Jung SY; Seong BL; Kang HY
    Vaccine; 2019 Aug; 37(35):4987-4995. PubMed ID: 31326252
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study.
    Linhares AC; Velázquez FR; Pérez-Schael I; Sáez-Llorens X; Abate H; Espinoza F; López P; Macías-Parra M; Ortega-Barría E; Rivera-Medina DM; Rivera L; Pavía-Ruz N; Nuñez E; Damaso S; Ruiz-Palacios GM; De Vos B; O'Ryan M; Gillard P; Bouckenooghe A;
    Lancet; 2008 Apr; 371(9619):1181-9. PubMed ID: 18395579
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A short report on highlights of world-wide development of RIX4414: a Latin American experience.
    Linhares AC; Ruiz-Palacios GM; Guerrero ML; Salinas B; Perez-Schael I; Clemens SA; Innis B; Yarzabal JP; Vespa G; Cervantes Y; Hardt K; De Vos B
    Vaccine; 2006 May; 24(18):3784-5. PubMed ID: 16098636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.